Kangstem Biotech Obtains Domestic Patent for Large-Scale Cultivation Technology of Adult Stem Cells
[Asia Economy Reporter Minji Lee] Kangstem Biotech announced on the 26th that it has obtained a domestic patent for its technology to develop high-performance adult stem cells, promoting proliferation, multipotency, and reprogramming.
This patent establishes standardized culture conditions through spherical growth that maintain an undifferentiated state, enabling the production of adult stem cells with CD49f-positive characteristics that promote stem cell proliferation, multipotency, and reprogramming without undergoing costly steps in the process.
Hot Picks Today
![“We’ve Hit Bottom”: Samsung Electronics and SK hynix “Undervalued at Global Financial Crisis Levels” Set for W-Shaped Rebound - But When? [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2026102210554370325_1792634143.png)
“We’ve Hit Bottom”: Samsung Electronics and SK hynix “Undervalued at Global Financial Crisis Levels” Set for W-Shaped Rebound - But When? [Weekend Money]
- "Shares Hit Daily Limit on 56 Billion Won News"... Marubeni Launches Tender Offer for K-Beauty Firm of 'Chae Sira's Husband' Kim Taewook
- "Even a sashimi restaurant grossing KRW 400 million a month has little left"... Business owners falling behind on loan payments and struggling with labor costs
- "Let's Give Unemployment Benefits to Those Who Find Jobs Quickly and Stay Long-Term"... Petition Takes Aim at Compensation for 'Voluntary Resignations'
- "If This Airs, I'm Dead"... Why a Restaurant Refused to Let Jeon Hyunmoo's Show Film
The company stated, "Based on this, we will be able to manufacture highly efficient stem cell therapeutics," adding, "It can also be used for the treatment of immune-related diseases as well as neurological, cardiovascular, and skeletal system disorders."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
